GREENZ

[DFLY]

Revolutions Medical Sales for the Current Quarter Top 200,000 RevVac(TM) Safety Syringes

MOUNT PLEASANT, SC, Sep 17, 2014 (Marketwired via COMTEX) -- Revolutions Medical Corporation (OTCQB: RMCP) announced that to date the Company is having its best quarter ever in terms of sales of its award winning RevVac(TM) auto retractable vacuum safety syringe. Through its marketing efforts over the past two years, which have shown all the benefits of the RevVac(TM) safety syringe including its one handed auto retraction safety feature, and that it cannot be reused to spread infectious diseases, the interest and market activity is increasing. With new disease threats like Ebola where safety to health care workers and limiting an outbreak is extremely important, along with the upcoming flu season, the Company is seeing more interest in the RevVac(TM) safety syringe than ever before.

Dr. Thomas Beahm, director of Revolutions Medical, states, "The Company has always been committed to health care safety and the prevention of the spread of infectious diseases. In this dangerous time, the Company has agreed to donate 50,000 RevVac(TM) safety syringes towards the fighting of the Ebola outbreak and other infectious diseases. It is difficult for the Company to know where the greatest need is for its product so if you have information to facilitate this donation please contact us at [e-mail]."

About Revolutions Medical Corporation

Revolutions Medical Corporation is a safety medical device company. Its proprietary products and technologies include: the RevVac(TM) safety syringe, safety blood drawing device and prefilled vacuum auto-retraction safety syringes.

For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com/

To be added to the Revolutions Medical investor email list, please email: [e-mail] with RMCP in the subject line.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.


CONTACT:

Revolutions Medical Corporation
Tel.: [phone]
Investor Relations


SOURCE: Revolutions Medical Corporation

(C) 2014 Marketwire L.P. All rights reserved.

-0-